Effect of ayurveda oral medicinein the management of high blood pressure.

Phase 2/3

Not yet recruiting

• Conditions: Essential (primary) hypertension. Ayurveda Condition: SIRAGATAVATAH,

• Registration Number: CTRI/2022/12/047918
• Lead Sponsor: Govt. Dhanwantari Ayurveda Medical College and Hospital ujjain

Brief Summary

this study is a randomised interventional clinical trial  to evaluate the efficacy of Kakubhadi Churna and Rasayana Vati  in the management of Raktagatavata w.s.r. to Essential hypertension. Total no. of patients 60 will be enrolled in present study. selected patients will be divided into 3 groups on the basis of computer generated randomization method.

group A  20 patients will be given Rasayana vati  2 tablets twice a day with lukewarm water



group B 20 patients will be given kakubhadi churna 3 gm twice a day with lukewarm water



group C 20 patients will be given both  Rasayana vati and Kakubhadi churna  twice daily with lukewarm water

Detailed Description

Not available

Study Timeline

• Last Update Posted: 2022-11-29
• Study Start: 2022-12-12

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

patients presenting with classical sign and symptoms as described in ayurvedic and modern medicine.

Exclusion Criteria

• 1 endocrine disease 2 renal disease 3 hypertension with cerebral complications 4 cerebral hemorrhages, convulsive seizures 5.
• toxemia of pregnancy 6 poisoning 7 pre eclampsia.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
diastolic blood pressure	1)At the baseline day | 2)after completion of trial i.e after 2 months | 3) total study period of 15 months
headache	1)At the baseline day | 2)after completion of trial i.e after 2 months | 3) total study period of 15 months
palpitation	1)At the baseline day | 2)after completion of trial i.e after 2 months | 3) total study period of 15 months
during this trial patients will be assessed on following parameters	1)At the baseline day | 2)after completion of trial i.e after 2 months | 3) total study period of 15 months
subjective criteria	1)At the baseline day | 2)after completion of trial i.e after 2 months | 3) total study period of 15 months
systolic blood pressure	1)At the baseline day | 2)after completion of trial i.e after 2 months | 3) total study period of 15 months
dizziness	1)At the baseline day | 2)after completion of trial i.e after 2 months | 3) total study period of 15 months
excessive sweating	1)At the baseline day | 2)after completion of trial i.e after 2 months | 3) total study period of 15 months
edema	1)At the baseline day | 2)after completion of trial i.e after 2 months | 3) total study period of 15 months
epitaxis	1)At the baseline day | 2)after completion of trial i.e after 2 months | 3) total study period of 15 months
objective criteria	1)At the baseline day | 2)after completion of trial i.e after 2 months | 3) total study period of 15 months

Trial Locations

Locations (1)

Dhanwantari Ayurveda Medical Hospital, Ujjain; 🇮🇳 Ujjain, MADHYA PRADESH, India

Dhanwantari Ayurveda Medical Hospital, Ujjain

🇮🇳Ujjain, MADHYA PRADESH, India

nikita

Principal investigator

6263854200

nikkujamadari12@gmail.com